Literature DB >> 22868069

Cementless total hip arthroplasty with modified oblique femoral shortening osteotomy in Crowe type IV congenital hip dislocation.

Onder İ Kiliçoğlu1, Mehmet Türker, Turgut Akgül, Onder Yazicioğlu.   

Abstract

Midterm results of cementless total hip arthroplasty in patients with Crowe type IV congenital dislocation of the hip were evaluated. A modified oblique subtrochanteric shortening osteotomy was used in all patients. A cylindrical femoral stem was used in all patients to stabilize the osteotomy. Mean follow-up was 82 months in 20 hips of 16 patients. Mean Merle D'Aubigné pain score increased from 2.52 to 5.65 points, function score improved from 4.0 to 5.3 points, and mobility score improved from 3.95 to 5.35. Mean greater trochanter height relative to the estimated hip center was 6.8 ± 2.0 cm preoperatively and -1 ± 0.2 cm postoperatively. Complications were dislocations in 3 patients, which were successfully managed without redislocation and fracture of greater trochanter in 3 patients, which healed uneventfully in 2 but with residual Trendelenburg gait in one. Total hip arthroplasty with modified oblique subtrochanteric shortening osteotomy is an effective technique for the treatment for Crowe type IV hip dislocation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22868069     DOI: 10.1016/j.arth.2012.06.014

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  24 in total

1.  Total hip arthroplasty in the developmental dysplasia of the hip using transverse subtrochanteric osteotomy.

Authors:  Fırat Ozan; Erdal Uzun; Kaan Gürbüz; Şemmi Koyuncu; Taşkın Altay; Cemil Kayalı
Journal:  J Orthop       Date:  2016-06-24

2.  Lesser trochanteric osteotomy in total hip arthroplasty for treating CROWE type IV developmental dysplasia of hip.

Authors:  Nirong Bao; Jia Meng; Liwu Zhou; Ting Guo; Xiaofeng Zeng; Jianning Zhao
Journal:  Int Orthop       Date:  2013-01-05       Impact factor: 3.075

3.  Long-Term Results of Total Hip Arthroplasty with Step-Cut Osteotomy in Crowe Type IV Dysplastic Hips.

Authors:  Orhan Akıncı; Ali Turgut
Journal:  Indian J Orthop       Date:  2021-11-22       Impact factor: 1.251

4.  Oblique femoral shortening osteotomy in total hip arthroplasty for high dislocation in patients with hip dysplasia.

Authors:  Luigi Zagra; Luca Bianchi; Andrea Mondini; Roberto Giacometti Ceroni
Journal:  Int Orthop       Date:  2015-07-07       Impact factor: 3.075

5.  Femoral shortening osteotomy in total hip arthroplasty for severe dysplasia: a comparison of two fixation techniques.

Authors:  Mehmet Faruk Çatma; Serhan Ünlü; Alper Öztürk; Atıf M Aksekili; Önder Ersan; Yalım Ateş
Journal:  Int Orthop       Date:  2016-03-03       Impact factor: 3.075

6.  Total hip arthroplasty with subtrochanteric osteotomy in neglected dysplastic hip.

Authors:  Eid Ahmed; El-Ganzoury Ibrahim; Bassiony Ayman
Journal:  Int Orthop       Date:  2014-10-11       Impact factor: 3.075

7.  Total Hip Arthroplasty for Crowe Type IV Developmental Dysplasia of the Hip Using a Titanium Mesh Cup and Subtrochanteric Femoral Osteotomy.

Authors:  Mengcun Chen; Daniel J Gittings; Shuhua Yang; Xianzhe Liu
Journal:  Iowa Orthop J       Date:  2018

8.  The ratio of femoral head diameter to pelvic height in the normal hips of a Chinese population.

Authors:  Yanbo Zhang; Jinlan Jiang; Chenyu Wang; Jianlin Zuo; Modi Yang; Jincheng Wang
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-08-27

9.  [Measurement and analysis of leg length in adults with unilateral developmental dysplasia of the hip].

Authors:  Zhaohui Song; Minzhi Yang; Renwen Guo; Dong Wu; Zhuo Zhang; Jiying Chen; Xiangpeng Kong; Wei Chai
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-05-15

10.  Initial Stability of Subtrochanteric Oblique Osteotomy in Uncemented Total Hip Arthroplasty: A Preliminary Finite Element Study.

Authors:  Liangtao Li; Mingyang Yu; Renshi Ma; Dong Zhu; Guishan Gu
Journal:  Med Sci Monit       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.